In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets

J Med Chem. 2012 Jan 12;55(1):126-39. doi: 10.1021/jm201082a. Epub 2012 Jan 4.

Abstract

Phospholipidosis (PLD) is a lysosomal storage disorder induced by compounds, notably cationic amphiphilic drugs, which although reversible interferes with cellular phospholipids.The in silico method described utilizes the amphiphilic moment ΔΔG(AM) (kJ/mol) together with basic pK(a) values to assign PLD inducing potential to a compound. The new model was accurate and sensitive (85% and 82%, respectively) when compared to other data sets. Therefore, the parallel in vitro assay for PLD was discontinued. The data reinforce our view that the amphiphilic moment is far more informative for determining a compound's potential to induce PLD than the combined use of basic pK(a) and ClogP values.

Publication types

  • Validation Study

MeSH terms

  • Animals
  • Cattle
  • Cells, Cultured
  • Computer Simulation*
  • Cornea / cytology
  • Drug-Related Side Effects and Adverse Reactions
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Lipidoses / chemically induced
  • Lipidoses / metabolism*
  • Lysosomal Storage Diseases / chemically induced
  • Lysosomal Storage Diseases / metabolism*
  • Models, Molecular*
  • Pharmaceutical Preparations / chemistry*
  • Phospholipids / chemistry*
  • Phospholipids / metabolism
  • Structure-Activity Relationship
  • Thermodynamics

Substances

  • Pharmaceutical Preparations
  • Phospholipids